The future of the global intravenous solution market looks promising with opportunities in the total parenteral nutrition and peripheral parenteral nutrition markets. The global intravenous solution market is expected to reach an estimated $23.3 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer, swift growth of medical facilities, including clinics, hospitals, and specialized care units, and growth of advanced healthcare technology.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the intravenous solution
market by product (total parenteral nutrition and peripheral parenteral
nutrition), nutrients (carbohydrates, vitamins & minerals, single dose
amino acids, parenteral lipid emulsion, and others), and region (North America,
Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major players
in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market,
carbohydrates, vitamins & minerals, single dose amino acids, and parenteral
lipid emulsion are the major segments of intravenous solution market by
nutrients. Lucintel forecasts that single dose amino acids will remain the
largest segment over the forecast period because it provides complete
nutritional support to patients who cannot eat or absorb enough food through regular
digestive means.Within this market, total parenteral nutrition is expected to
witness the higher growth because it provides complete nutritional support to
patients.
Europe is expected to
witness highest growth over the forecast period because of strong presence of
key players, ease of drug availability, and established healthcare
infrastructure.
Pfizer, Otsuka
Pharmaceutical, Sichuan Kelun Pharmaceutical, Vifor Pharma Management, Grifols,
Henry Schein, Soxa Formulations & Research, B. Braun Melsungen, Baxter
International, and Fresenius Kabi are the major suppliers in the intravenous
solution market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Explore Our Latest Publications
Plastic Healthcare Packaging
Market
Smoking Cessation and Nicotine
De-Addiction Products Market
No comments:
Post a Comment